Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DaeYong Lee

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Family Issues|April 11, 2024
COVID-19 and Family Distancing Efforts: Contextual Demographic and Family Conflict CorrelatesSesong Jeon, Daeyong Lee, Carl F Weems
Biomaterials Research|September 9, 2016
A branched TAT cell-penetrating peptide as a novel delivery carrier for the efficient gene transfectionChanuk Jeong, Jisang Yoo, DaeYong Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2024
Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapyEun-Hye Kim, Katelyn Wahl, Erica Guelfi, et al.
Trends in Cancer|August 27, 2025
Leveraging phagocytosis using nanomedicines for cancer immunotherapySusam Lee, Hoyeon Nam, Katelyn Wahl, et al.
Polymers|April 10, 2019
Stimuli-Responsive Polypeptides for Biomedical ApplicationsDaeYong Lee, N Sanoj Rejinold, Seong Dong Jeong, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 29, 2021
Harnessing Innate Immunity Using Biomaterials for Cancer ImmunotherapyDaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Acta Biomaterialia|May 22, 2017
pH-controllable cell-penetrating polypeptide that exhibits cancer targetingDaeYong Lee, Ilkoo Noh, Jisang Yoo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2017
Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapyJisang Yoo, N Sanoj Rejinold, DaeYong Lee, et al.
Biomaterials|January 15, 2019
Development of apoptosis-inducing polypeptide via simultaneous mitochondrial membrane disruption and Ca<sup>2+</sup> deliveryJongHoon Ha, DaeYong Lee, Soo-Hwan Lee, et al.
Trends in Cancer|October 15, 2023
Targeting phagocytosis to enhance antitumor immunity: (Trends in Cancer, 9:8 p:650-665, 2023)Kristin Huntoon, DaeYong Lee, Shiyan Dong, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Family Issues|April 11, 2024
COVID-19 and Family Distancing Efforts: Contextual Demographic and Family Conflict CorrelatesSesong Jeon, Daeyong Lee, Carl F Weems
Biomaterials Research|September 9, 2016
A branched TAT cell-penetrating peptide as a novel delivery carrier for the efficient gene transfectionChanuk Jeong, Jisang Yoo, DaeYong Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2024
Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapyEun-Hye Kim, Katelyn Wahl, Erica Guelfi, et al.
Trends in Cancer|August 27, 2025
Leveraging phagocytosis using nanomedicines for cancer immunotherapySusam Lee, Hoyeon Nam, Katelyn Wahl, et al.
Polymers|April 10, 2019
Stimuli-Responsive Polypeptides for Biomedical ApplicationsDaeYong Lee, N Sanoj Rejinold, Seong Dong Jeong, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 29, 2021
Harnessing Innate Immunity Using Biomaterials for Cancer ImmunotherapyDaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Acta Biomaterialia|May 22, 2017
pH-controllable cell-penetrating polypeptide that exhibits cancer targetingDaeYong Lee, Ilkoo Noh, Jisang Yoo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2017
Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapyJisang Yoo, N Sanoj Rejinold, DaeYong Lee, et al.
Biomaterials|January 15, 2019
Development of apoptosis-inducing polypeptide via simultaneous mitochondrial membrane disruption and Ca<sup>2+</sup> deliveryJongHoon Ha, DaeYong Lee, Soo-Hwan Lee, et al.
Trends in Cancer|October 15, 2023
Targeting phagocytosis to enhance antitumor immunity: (Trends in Cancer, 9:8 p:650-665, 2023)Kristin Huntoon, DaeYong Lee, Shiyan Dong, et al.
Pageof 4